Agios Pharmaceuticals Inc (NASDAQ:AGIO)
| 22.15 Delayed Data As of 4:01pm ET |  -0.20 / -0.89%Today’s Change | 16.75 Today|||52-Week Range 58.61 | -32.61% Year-to-Date |
Latest AGIO News | Press Releases
No recent news for Agios Pharmaceuticals Inc.
Today’s Trading
| Previous close | 22.35 |
| Today’s open | 22.29 |
| Day’s range | 21.71 - 22.46 |
| Volume | 13,683 |
| Average volume (3 months) | 661,943 |
| Market cap | $1.2B |
Data as of 4:01pm ET, 06/30/2022
Growth & Valuation
| Earnings growth (last year) | -34.04% |
| Earnings growth (this year) | -125.48% |
| Earnings growth (next 5 years) | +2.16% |
| Revenue growth (last year) | -100.00% |
| P/E ratio | NM |
| Price/Sales | -- |
| Price/Book | 0.95 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| MDGLMadrigal Pharmaceuti... | -0.26 | -0.37% |
| KURAKura Oncology Inc | +0.08 | +0.44% |
| VCELVericel Corp | -0.18 | -0.71% |
| RETAReata Pharmaceutical... | -1.67 | -5.21% |
Data as of 4:01pm ET, 06/30/2022
Financials
| Next reporting date | August 4, 2022 |
| EPS forecast (this quarter) | -$1.69 |
| Annual revenue (last year) | $0.00 |
| Annual profit (last year) | -$384.4M |
| Net profit margin | -- |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters Cambridge, Massachusetts |
Forecasts
